Literature DB >> 16169012

The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy.

Nathan T Wright1, Kristen M Varney, Karen C Ellis, Joseph Markowitz, Rossitza K Gitti, Danna B Zimmer, David J Weber.   

Abstract

S100A1 is an EF-hand-containing Ca(2+)-binding protein that undergoes a conformational change upon binding calcium as is necessary to interact with protein targets and initiate a biological response. To better understand how calcium influences the structure and function of S100A1, the three-dimensional structure of calcium-bound S100A1 was determined by multidimensional NMR spectroscopy and compared to the previously determined structure of apo. In total, 3354 nuclear Overhauser effect-derived distance constraints, 240 dihedral constraints, 160 hydrogen bond constraints, and 362 residual dipolar coupling restraints derived from a series of two-dimensional, three-dimensional, and four-dimensional NMR experiments were used in its structure determination (>21 constraints per residue). As with other dimeric S100 proteins, S100A1 is a symmetric homodimer with helices 1, 1', 4, and 4' associating into an X-type four-helix bundle at the dimer interface. Within each subunit there are four alpha-helices and a short antiparallel beta-sheet typical of two helix-loop-helix EF-hand calcium-binding domains. The addition of calcium did not change the interhelical angle of helices 1 and 2 in the pseudo EF-hand significantly; however, there was a large reorientation of helix 3 in the typical EF-hand. The large conformational change exposes a hydrophobic cleft, defined by residues in the hinge region, the C terminus, and regions of helix 3, which are important for the interaction between S100A1 and a peptide (TRTK-12) derived from the actin-capping protein CapZ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169012     DOI: 10.1016/j.jmb.2005.08.027

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling.

Authors:  Benjamin L Prosser; Nathan T Wright; Erick O Hernãndez-Ochoa; Kristen M Varney; Yewei Liu; Rotimi O Olojo; Danna B Zimmer; David J Weber; Martin F Schneider
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

2.  Structure of calcium-bound human S100A13 at pH 7.5 at 1.8 A resolution.

Authors:  Fabiana Lica Imai; Koji Nagata; Naoto Yonezawa; Minoru Nakano; Masaru Tanokura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-01-31

3.  Solution structure and small angle scattering analysis of TraI (381-569).

Authors:  Nathan T Wright; Madushi Raththagala; Casey W Hemmis; Sheldon Edwards; Joseph E Curtis; Susan Krueger; Joel F Schildbach
Journal:  Proteins       Date:  2012-06-18

4.  Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons.

Authors:  Erick O Hernández-Ochoa; Benjamin L Prosser; Nathan T Wright; Minerva Contreras; David J Weber; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

5.  Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form.

Authors:  Puja Pathuri; Lutz Vogeley; Hartmut Luecke
Journal:  J Mol Biol       Date:  2008-05-07       Impact factor: 5.469

6.  Chemical shift assignments of a reduced N-terminal truncation mutant of the disulfide bond isomerase TrbB from plasmid F, TrbBΔ29.

Authors:  Casey W Hemmis; Nathan T Wright; Ananya Majumdar; Joel F Schildbach
Journal:  Biomol NMR Assign       Date:  2014-04-26       Impact factor: 0.746

7.  Molecular Basis of S100A1 Activation at Saturating and Subsaturating Calcium Concentrations.

Authors:  Caitlin E Scott; Peter M Kekenes-Huskey
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

Review 8.  S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.

Authors:  Mirko Völkers; David Rohde; Chelain Goodman; Patrick Most
Journal:  J Biomed Biotechnol       Date:  2010-03-28

Review 9.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

10.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.